122 related articles for article (PubMed ID: 20847449)
1. Combining MRI and MRS to distinguish between Alzheimer's disease and healthy controls.
Westman E; Wahlund LO; Foy C; Poppe M; Cooper A; Murphy D; Spenger C; Lovestone S; Simmons A
J Alzheimers Dis; 2010; 22(1):171-81. PubMed ID: 20847449
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging and magnetic resonance spectroscopy for detection of early Alzheimer's disease.
Westman E; Wahlund LO; Foy C; Poppe M; Cooper A; Murphy D; Spenger C; Lovestone S; Simmons A
J Alzheimers Dis; 2011; 26 Suppl 3():307-19. PubMed ID: 21971470
[TBL] [Abstract][Full Text] [Related]
3. Multivariate analysis of MRI data for Alzheimer's disease, mild cognitive impairment and healthy controls.
Westman E; Simmons A; Zhang Y; Muehlboeck JS; Tunnard C; Liu Y; Collins L; Evans A; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Lovestone S; Spenger C; Wahlund LO;
Neuroimage; 2011 Jan; 54(2):1178-87. PubMed ID: 20800095
[TBL] [Abstract][Full Text] [Related]
4. Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease.
Westman E; Cavallin L; Muehlboeck JS; Zhang Y; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Spenger C; Lovestone S; Simmons A; Wahlund LO;
PLoS One; 2011; 6(7):e22506. PubMed ID: 21811624
[TBL] [Abstract][Full Text] [Related]
5. Classification and prediction of clinical diagnosis of Alzheimer's disease based on MRI and plasma measures of α-/γ-tocotrienols and γ-tocopherol.
Mangialasche F; Westman E; Kivipelto M; Muehlboeck JS; Cecchetti R; Baglioni M; Tarducci R; Gobbi G; Floridi P; Soininen H; Kłoszewska I; Tsolaki M; Vellas B; Spenger C; Lovestone S; Wahlund LO; Simmons A; Mecocci P;
J Intern Med; 2013 Jun; 273(6):602-21. PubMed ID: 23343471
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance spectroscopy and brain volumetry in mild cognitive impairment. A prospective study.
Fayed N; Modrego PJ; García-Martí G; Sanz-Requena R; Marti-Bonmatí L
Magn Reson Imaging; 2017 May; 38():27-32. PubMed ID: 27964994
[TBL] [Abstract][Full Text] [Related]
7. AddNeuroMed and ADNI: similar patterns of Alzheimer's atrophy and automated MRI classification accuracy in Europe and North America.
Westman E; Simmons A; Muehlboeck JS; Mecocci P; Vellas B; Tsolaki M; Kłoszewska I; Soininen H; Weiner MW; Lovestone S; Spenger C; Wahlund LO; ;
Neuroimage; 2011 Oct; 58(3):818-28. PubMed ID: 21763442
[TBL] [Abstract][Full Text] [Related]
8. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls.
O'Brien JT; Ames D; Desmond P; Lichtenstein M; Binns D; Schweitzer I; Davis S; Tress B
Int Psychogeriatr; 2001 Jun; 13(2):149-61. PubMed ID: 11495391
[TBL] [Abstract][Full Text] [Related]
9. 3.0 T MRI arterial spin labeling and magnetic resonance spectroscopy technology in the application of Alzheimer's disease.
Zou JX; Wang MJ; Lei XJ; Chen XG
Exp Gerontol; 2014 Dec; 60():31-6. PubMed ID: 25220149
[TBL] [Abstract][Full Text] [Related]
10. Volumetric MRI vs clinical predictors of Alzheimer disease in mild cognitive impairment.
Fleisher AS; Sun S; Taylor C; Ward CP; Gamst AC; Petersen RC; Jack CR; Aisen PS; Thal LJ
Neurology; 2008 Jan; 70(3):191-9. PubMed ID: 18195264
[TBL] [Abstract][Full Text] [Related]
11. Classification of Alzheimer's Disease and Mild Cognitive Impairment Based on Cortical and Subcortical Features from MRI T1 Brain Images Utilizing Four Different Types of Datasets.
Toshkhujaev S; Lee KH; Choi KY; Lee JJ; Kwon GR; Gupta Y; Lama RK
J Healthc Eng; 2020; 2020():3743171. PubMed ID: 32952988
[TBL] [Abstract][Full Text] [Related]
12. Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease.
Chincarini A; Bosco P; Calvini P; Gemme G; Esposito M; Olivieri C; Rei L; Squarcia S; Rodriguez G; Bellotti R; Cerello P; De Mitri I; Retico A; Nobili F;
Neuroimage; 2011 Sep; 58(2):469-80. PubMed ID: 21718788
[TBL] [Abstract][Full Text] [Related]
13. Automated MRI measures identify individuals with mild cognitive impairment and Alzheimer's disease.
Desikan RS; Cabral HJ; Hess CP; Dillon WP; Glastonbury CM; Weiner MW; Schmansky NJ; Greve DN; Salat DH; Buckner RL; Fischl B;
Brain; 2009 Aug; 132(Pt 8):2048-57. PubMed ID: 19460794
[TBL] [Abstract][Full Text] [Related]
14. Multimodal imaging in diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: value of magnetic resonance spectroscopy, perfusion, and diffusion tensor imaging of the posterior cingulate region.
Zimny A; Szewczyk P; Trypka E; Wojtynska R; Noga L; Leszek J; Sasiadek M
J Alzheimers Dis; 2011; 27(3):591-601. PubMed ID: 21841260
[TBL] [Abstract][Full Text] [Related]
15. Random Forest ensembles for detection and prediction of Alzheimer's disease with a good between-cohort robustness.
Lebedev AV; Westman E; Van Westen GJ; Kramberger MG; Lundervold A; Aarsland D; Soininen H; Kłoszewska I; Mecocci P; Tsolaki M; Vellas B; Lovestone S; Simmons A;
Neuroimage Clin; 2014; 6():115-25. PubMed ID: 25379423
[TBL] [Abstract][Full Text] [Related]
16. 1H-MRS, MRI-based hippocampal volumetry, and 99mTc-HMPAO-SPECT in normal aging, age-associated memory impairment, and probable Alzheimer's disease.
Parnetti L; Lowenthal DT; Presciutti O; Pelliccioli GP; Palumbo R; Gobbi G; Chiarini P; Palumbo B; Tarducci R; Senin U
J Am Geriatr Soc; 1996 Feb; 44(2):133-8. PubMed ID: 8576501
[TBL] [Abstract][Full Text] [Related]
17. Multivariate analysis of structural MRI and PET (FDG and 18F-AV-45) for Alzheimer's disease and its prodromal stages.
Zhou Q; Goryawala M; Cabrerizo M; Barker W; Loewenstein D; Duara R; Adjouadi M
Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():1051-4. PubMed ID: 25570142
[TBL] [Abstract][Full Text] [Related]
18. Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus.
Colliot O; Chételat G; Chupin M; Desgranges B; Magnin B; Benali H; Dubois B; Garnero L; Eustache F; Lehéricy S
Radiology; 2008 Jul; 248(1):194-201. PubMed ID: 18458242
[TBL] [Abstract][Full Text] [Related]
19. A review of 1H MR spectroscopy findings in Alzheimer's disease.
Soher BJ; Doraiswamy PM; Charles HC
Neuroimaging Clin N Am; 2005 Nov; 15(4):847-52, xi. PubMed ID: 16443495
[TBL] [Abstract][Full Text] [Related]
20. [Cognitive impairment: classification by proton magnetic resonance spectroscopy and the contributions of conventional magnetic resonance imaging].
Martínez-Bisbal MC; Arana E; Martí-Bonmatí L; Martínez-Granados B; Celda B
Radiologia; 2006; 48(5):301-7. PubMed ID: 17168239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
